Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MREO | MEREO BIOPHARMA GROUP PLC | $389.92M | $2.78 | $6.50 | 133.81% | Strong Buy | 2 | 999.90% | N/A | N/A | N/A | ||||
| OCS | OCULIS HOLDING AG | $439.06M | $11.98 | $30.50 | 154.59% | Strong Buy | 4 | 199.71% | N/A | N/A | N/A | ||||
| VCYT | VERACYTE INC | $1.49B | $19.90 | $27.33 | 37.35% | Hold | 3 | 10.33% | N/A | N/A | N/A | ||||
| STTK | SHATTUCK LABS INC | $470.00M | $9.90 | $20.00 | 102.02% | Buy | 2 | 363.27% | N/A | N/A | N/A | ||||
| CRNX | CRINETICS PHARMACEUTICALS INC | $3.01B | $43.32 | $57.89 | 33.63% | Strong Buy | 9 | 174.31% | N/A | N/A | N/A | ||||
| IMCR | IMMUNOCORE HOLDINGS PLC | $2.91B | $58.47 | $82.13 | 40.46% | Strong Buy | 8 | 12.02% | N/A | N/A | N/A | ||||
| VRDN | VIRIDIAN THERAPEUTICS INC | $817.86M | $13.03 | $34.43 | 164.23% | Buy | 7 | 504.64% | N/A | N/A | N/A | ||||
| IFRX | INFLARX NV | $80.08M | $1.36 | $13.50 | 892.65% | Strong Buy | 2 | 799.80% | N/A | N/A | N/A | ||||
| APRE | APREA THERAPEUTICS INC | $28.07M | $5.17 | $15.50 | 199.81% | Buy | 2 | 0.95% | N/A | N/A | N/A | ||||
| KRRO | KORRO BIO INC | $505.30M | $62.99 | $126.25 | 100.43% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| QSI | QUANTUM-SI INC | $236.76M | $1.67 | $4.00 | 139.52% | Buy | 1 | 182.41% | N/A | N/A | N/A | ||||
| PRTC | PURETECH HEALTH PLC | $765.50M | $27.48 | N/A | N/A | N/A | N/A | 32.38% | N/A | N/A | N/A | ||||
| IMTX | IMMATICS NV | $859.28M | $10.15 | N/A | N/A | N/A | N/A | 13.76% | N/A | N/A | N/A | ||||
| CMRX | CHIMERIX INC | $80.82M | $0.91 | $11.00 | 1,114.13% | Buy | 1 | 470.51% | N/A | N/A | N/A | ||||
| LQDA | LIQUIDIA CORP | $954.15M | $12.55 | $21.60 | 72.11% | Buy | 5 | 118.22% | N/A | N/A | N/A | ||||
| ATAI | ATAI LIFE SCIENCES NV | $310.47M | $1.87 | $10.50 | 461.50% | Strong Buy | 2 | 68.42% | N/A | N/A | N/A | ||||
| BLUE | BLUEBIRD BIO INC | $100.92M | $0.92 | $5.71 | 518.96% | Hold | 8 | 150.43% | N/A | N/A | N/A | ||||
| MOLN | MOLECULAR PARTNERS AG | $127.47M | $3.88 | $4.50 | 15.98% | Hold | 1 | -4.56% | N/A | N/A | N/A | ||||
| MESO | MESOBLAST LTD | $631.21M | $6.22 | N/A | N/A | N/A | N/A | 54.19% | N/A | N/A | N/A | ||||
| DNTH | DIANTHUS THERAPEUTICS INC | $625.67M | $21.32 | $41.75 | 95.83% | Strong Buy | 4 | -0.85% | N/A | N/A | N/A | ||||
| QNCX | QUINCE THERAPEUTICS INC | $45.81M | $1.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| AUPH | AURINIA PHARMACEUTICALS INC | $727.43M | $5.03 | $10.33 | 105.43% | Strong Buy | 3 | 34.38% | N/A | N/A | N/A | ||||
| GLMD | GALMED PHARMACEUTICALS LTD | $2.02M | $0.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| MTEM | MOLECULAR TEMPLATES INC | $8.81M | $1.64 | N/A | N/A | N/A | N/A | -47.20% | N/A | N/A | N/A | ||||
| HOTH | HOTH THERAPEUTICS INC | $5.15M | $1.17 | $5.50 | 370.09% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| CYCN | CYCLERION THERAPEUTICS INC | $7.51M | $2.77 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CASI | CASI PHARMACEUTICALS INC | $32.64M | $2.44 | $12.00 | 391.80% | Buy | 1 | 61.96% | N/A | N/A | N/A | ||||
| ARVN | ARVINAS INC | $2.22B | $32.54 | $59.31 | 82.26% | Strong Buy | 13 | 58.19% | N/A | N/A | N/A | ||||
| CRBU | CARIBOU BIOSCIENCES INC | $347.71M | $3.85 | $21.50 | 458.44% | Buy | 2 | -26.72% | N/A | N/A | N/A | ||||
| BEAM | BEAM THERAPEUTICS INC | $1.86B | $22.74 | $42.29 | 85.95% | Buy | 7 | -50.54% | N/A | N/A | N/A | ||||
| ABSI | ABSCI CORP | $510.91M | $4.53 | $9.25 | 104.19% | Strong Buy | 4 | 110.39% | N/A | N/A | N/A | ||||
| YMAB | Y-MABS THERAPEUTICS INC | $669.35M | $15.29 | $24.33 | 59.14% | Strong Buy | 3 | 14.09% | N/A | N/A | N/A | ||||
| NTLA | INTELLIA THERAPEUTICS INC | $2.03B | $21.17 | $59.75 | 182.24% | Buy | 8 | 45.90% | N/A | N/A | N/A | ||||
| KROS | KEROS THERAPEUTICS INC | $2.02B | $56.24 | $90.20 | 60.38% | Strong Buy | 5 | 768.53% | N/A | N/A | N/A | ||||
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | $6.53M | $4.81 | N/A | N/A | N/A | N/A | 1,601.51% | N/A | N/A | N/A | ||||
| CCCC | C4 THERAPEUTICS INC | $443.85M | $6.47 | $10.00 | 54.56% | Buy | 5 | 112.66% | N/A | N/A | N/A | ||||
| XOMA | XOMA CORP | $298.09M | $25.64 | $74.00 | 188.61% | Buy | 1 | 73.97% | N/A | N/A | N/A | ||||
| INO | INOVIO PHARMACEUTICALS INC | $237.44M | $10.16 | $21.00 | 106.69% | Buy | 3 | 522.90% | N/A | N/A | N/A | ||||
| SPRC | SCISPARC LTD | $1.33M | $1.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| PGEN | PRECIGEN INC | $353.47M | $1.42 | $10.00 | 604.23% | Buy | 2 | 198.74% | N/A | N/A | N/A | ||||
| GTHX | G1 THERAPEUTICS INC | $208.28M | $3.99 | $8.00 | 100.50% | Buy | 2 | 20.21% | N/A | N/A | N/A | ||||
| SWTX | SPRINGWORKS THERAPEUTICS INC | $3.20B | $43.38 | $66.60 | 53.53% | Strong Buy | 5 | 342.35% | N/A | N/A | N/A | ||||
| GLYC | GLYCOMIMETICS INC | $119.56M | $1.86 | $10.00 | 439.08% | Buy | 2 | 1,575.56% | N/A | N/A | N/A | ||||
| IKNA | IKENA ONCOLOGY INC | $62.25M | $1.29 | $9.50 | 636.43% | Buy | 2 | 48.45% | N/A | N/A | N/A | ||||
| ALLO | ALLOGENE THERAPEUTICS INC | $514.04M | $3.04 | $8.75 | 187.83% | Strong Buy | 4 | 352.37% | N/A | N/A | N/A | ||||
| QTTB | Q32 BIO INC | $85.88M | $26.59 | $47.50 | 78.64% | Strong Buy | 2 | 341.21% | N/A | N/A | N/A | ||||
| IMNM | IMMUNOME INC | $851.84M | $14.27 | $34.00 | 138.26% | Strong Buy | 2 | 45.81% | N/A | N/A | N/A | ||||
| MRNA | MODERNA INC | $41.59B | $108.85 | $127.14 | 16.81% | Buy | 7 | 1.67% | N/A | N/A | N/A | ||||
| CUE | CUE BIOPHARMA INC | $69.07M | $1.42 | $8.00 | 463.38% | Strong Buy | 4 | 62.69% | N/A | N/A | N/A | ||||
| PLUR | PLURI INC | $26.39M | $5.09 | N/A | N/A | N/A | N/A | 227.30% | N/A | N/A | N/A | ||||
| ABCL | ABCELLERA BIOLOGICS INC | $1.14B | $3.90 | $11.50 | 194.87% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| TARS | TARSUS PHARMACEUTICALS INC | $1.12B | $32.76 | $48.00 | 46.52% | Buy | 5 | 165.79% | N/A | N/A | N/A | ||||
| DNLI | DENALI THERAPEUTICS INC | $2.17B | $15.56 | $44.67 | 187.06% | Strong Buy | 6 | -10.36% | N/A | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $11.66B | $124.25 | $155.54 | 25.18% | Strong Buy | 13 | 34.48% | N/A | N/A | N/A | ||||
| LYEL | LYELL IMMUNOPHARMA INC | $584.42M | $2.30 | $6.00 | 160.87% | Buy | 1 | 7,592.31% | N/A | -68.28% | -59.63% | ||||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $847.12M | $8.75 | $13.50 | 54.29% | Strong Buy | 4 | 94.05% | N/A | N/A | N/A | ||||
| MRNS | MARINUS PHARMACEUTICALS INC | $78.69M | $1.44 | $13.17 | 814.38% | Buy | 6 | 70.93% | N/A | N/A | N/A | ||||
| MIST | MILESTONE PHARMACEUTICALS INC | $88.23M | $1.66 | $15.00 | 803.61% | Strong Buy | 2 | 402.59% | N/A | N/A | N/A | ||||
| COCP | COCRYSTAL PHARMA INC | $15.83M | $1.56 | $10.00 | 542.67% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| CVKD | CADRENAL THERAPEUTICS INC | $6.85M | $0.43 | $3.50 | 717.76% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| MGNX | MACROGENICS INC | $980.18M | $15.70 | $21.56 | 37.30% | Strong Buy | 9 | 55.32% | N/A | N/A | N/A | ||||
| LXRX | LEXICON PHARMACEUTICALS INC | $393.98M | $1.60 | N/A | N/A | N/A | N/A | 451.87% | N/A | N/A | N/A | ||||
| LUMO | LUMOS PHARMA INC | $22.66M | $2.80 | $22.00 | 687.12% | Buy | 2 | 180.56% | N/A | N/A | N/A | ||||
| INVA | INNOVIVA INC | $958.53M | $15.16 | N/A | N/A | N/A | N/A | N/A | N/A | 4.87% | 2.64% | ||||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.80M | $0.24 | N/A | N/A | N/A | N/A | 125.84% | N/A | N/A | N/A | ||||
| PALI | PALISADE BIO INC | $5.41M | $6.35 | $22.50 | 254.33% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| NGNE | NEUROGENE INC | $388.55M | $30.23 | $43.00 | 42.24% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SLRN | ACELYRIN INC | $449.53M | $4.57 | $14.80 | 223.85% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| ALPN | ALPINE IMMUNE SCIENCES INC | $4.23B | $64.57 | $55.86 | -13.49% | Buy | 7 | -10.79% | N/A | N/A | N/A | ||||
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $300.24M | $2.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| KRON | KRONOS BIO INC | $57.69M | $0.96 | $4.25 | 342.71% | Strong Buy | 2 | -17.74% | N/A | N/A | N/A | ||||
| ABEO | ABEONA THERAPEUTICS INC | $86.72M | $3.17 | $36.00 | 1,035.65% | Strong Buy | 1 | 189.78% | N/A | N/A | N/A | ||||
| ALEC | ALECTOR INC | $502.68M | $5.25 | $19.25 | 266.67% | Strong Buy | 4 | 13.52% | N/A | N/A | N/A | ||||
| OVID | OVID THERAPEUTICS INC | $222.74M | $3.15 | $9.50 | 201.59% | Strong Buy | 2 | 274.95% | N/A | N/A | N/A | ||||
| PPBT | PURPLE BIOTECH LTD | $10.18M | $0.51 | $10.50 | 1,946.78% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| KYMR | KYMERA THERAPEUTICS INC | $2.15B | $35.21 | $41.67 | 18.34% | Buy | 9 | -1.66% | N/A | N/A | N/A | ||||
| LYRA | LYRA THERAPEUTICS INC | $312.46M | $5.23 | $11.50 | 119.89% | Strong Buy | 2 | 105.73% | N/A | N/A | N/A | ||||
| VIR | VIR BIOTECHNOLOGY INC | $1.09B | $8.04 | $45.00 | 459.70% | Buy | 3 | -5.58% | N/A | N/A | N/A | ||||
| ANAB | ANAPTYSBIO INC | $515.72M | $19.27 | $44.63 | 131.58% | Buy | 8 | 34.06% | N/A | N/A | N/A | ||||
| CRDF | CARDIFF ONCOLOGY INC | $186.75M | $4.18 | $10.50 | 151.20% | Strong Buy | 2 | -32.79% | N/A | N/A | N/A | ||||
| RLAY | RELAY THERAPEUTICS INC | $832.99M | $6.35 | $23.50 | 270.08% | Strong Buy | 2 | -9.41% | N/A | N/A | N/A | ||||
| TVTX | TRAVERE THERAPEUTICS INC | $414.74M | $5.45 | $12.20 | 123.85% | Buy | 5 | 43.27% | N/A | N/A | N/A | ||||
| LSTA | LISATA THERAPEUTICS INC | $23.51M | $2.83 | $15.00 | 430.04% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| VRNA | VERONA PHARMA PLC | $1.23B | $15.24 | $33.67 | 120.91% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| AVXL | ANAVEX LIFE SCIENCES CORP | $280.00M | $3.41 | $40.00 | 1,073.02% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ATXS | ASTRIA THERAPEUTICS INC | $494.13M | $9.00 | $21.25 | 136.11% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| CLDX | CELLDEX THERAPEUTICS INC | $2.07B | $37.02 | $66.00 | 78.28% | Strong Buy | 4 | -2.54% | N/A | N/A | N/A | ||||
| TRVI | TREVI THERAPEUTICS INC | $182.74M | $2.65 | $8.50 | 220.75% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| ATOS | ATOSSA THERAPEUTICS INC | $187.96M | $1.50 | $4.00 | 166.67% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| RIGL | RIGEL PHARMACEUTICALS INC | $197.30M | $1.13 | $5.81 | 416.71% | Buy | 4 | 23.54% | N/A | N/A | N/A | ||||
| ELVN | ENLIVEN THERAPEUTICS INC | $723.17M | $17.49 | $34.00 | 94.40% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| DTIL | PRECISION BIOSCIENCES INC | $67.92M | $9.82 | $60.00 | 511.00% | Buy | 1 | -9.49% | N/A | N/A | N/A | ||||
| LABP | LANDOS BIOPHARMA INC | $69.13M | $22.18 | $20.42 | -7.94% | Hold | 1 | N/A | N/A | N/A | N/A | ||||
| IOBT | IO BIOTECH INC | $96.19M | $1.46 | $8.00 | 447.95% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| TCRX | TSCAN THERAPEUTICS INC | $353.37M | $7.38 | $11.33 | 53.56% | Strong Buy | 3 | -4.23% | N/A | N/A | N/A | ||||
| VCEL | VERICEL CORP | $2.23B | $46.11 | $53.50 | 16.03% | Strong Buy | 2 | 26.40% | N/A | N/A | N/A | ||||
| DNA | GINKGO BIOWORKS HOLDINGS INC | $1.82B | $0.85 | $2.20 | 160.05% | Hold | 3 | 21.73% | N/A | N/A | N/A | ||||
| HOWL | WEREWOLF THERAPEUTICS INC | $273.09M | $6.39 | $13.50 | 111.27% | Buy | 2 | 29.76% | N/A | N/A | N/A | ||||
| ETNB | 89BIO INC | $802.24M | $8.58 | $28.20 | 228.67% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| TERN | TERNS PHARMACEUTICALS INC | $307.10M | $4.75 | $13.50 | 184.21% | Buy | 5 | N/A | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.